446 related articles for article (PubMed ID: 16951223)
1. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
Wilson W; Baldwin AS
Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
5. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
Bilim V; Ougolkov A; Yuuki K; Naito S; Kawazoe H; Muto A; Oya M; Billadeau D; Motoyama T; Tomita Y
Br J Cancer; 2009 Dec; 101(12):2005-14. PubMed ID: 19920820
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
9. ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer.
Zhou W; Wang L; Gou SM; Wang TL; Zhang M; Liu T; Wang CY
Cancer Lett; 2012 Mar; 316(2):178-86. PubMed ID: 22100174
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
Mamaghani S; Patel S; Hedley DW
BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
[TBL] [Abstract][Full Text] [Related]
15. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
Johnson JL; de Mejia EG
Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
